z-logo
open-access-imgOpen Access
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)
Author(s) -
Zhijie Wang,
Lin Wu,
Baolan Li,
Ying Cheng,
Xiaoling Li,
Xicheng Wang,
Liang Han,
Xiaohong Wu,
Yun Fan,
Yan Yu,
Dongqing Lv,
Jianhua Shi,
Jianjin Huang,
Shaozhang Zhou,
Baohui Han,
Guogui Sun,
Qisen Guo,
Youxin Ji,
Xiaoli Zhu,
Sheng Hu,
Wei Zhang,
Qiming Wang,
Yuming Jia,
Ziping Wang,
Yong Song,
Jingxun Wu,
Meiqi Shi,
Xingya Li,
Zhigang Han,
Yunpeng Liu,
Zhuang Yu,
Anwen Liu,
Xiuwen Wang,
Caicun Zhou,
Diansheng Zhong,
Liyun Miao,
Zhihong Zhang,
Hui Zhao,
J. Y. Yang,
Dong Wang,
Yingyi Wang,
Qiang Li,
Xiaodong Zhang,
Mei Ji,
Zhenzhou Yang,
Jiuwei Cui,
Beili Gao,
Buhai Wang,
Hu Liu,
Lei Nie,
Mei He,
Jin Shi,
Wei Gu,
Yongqian Shu,
Tong Zhou,
Jian Feng,
Xinmei Yang,
Cheng Huang,
Bo Zhu,
Yu Yao,
Xiongwen Tang,
Jianjun Yu,
Ellen Maher,
Hui Feng,
Sheng Yao,
Patricia Keegan,
Jie Wang
Publication year - 2022
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.22.00727
Subject(s) - medicine , hazard ratio , interim analysis , lung cancer , placebo , clinical endpoint , chemotherapy , oncology , progression free survival , adverse effect , surgery , gastroenterology , confidence interval , randomized controlled trial , pathology , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom